| ADM | adrenomedullin |
| ANA | anagrelide |
| APs | activated platelets |
| ASA | acetylsalycilic acid |
| CALR | calreticulin |
| CD | cluster of differentiation |
| CEC | circulating endothelial cells |
| cfDNA | cell-free DNA |
| CK | cytokine(s) |
| CML | chronic myeloid leukemia |
| CPA | circulating procoagulant activity of plasma |
| CV risk | cardiovascular risk |
| ED-1 | endothelin-1 |
| ELISA | enzyme-linked immunoassay |
| EM+IGA | electron microscopy and immunogold analysis |
| EMPs | endothelial MPs |
| EMVs | endothelial MVs |
| ET | essential thrombocythemia |
| ETP | endogeneous thrombin potential |
| GMPs | granulocyte-derived MPs |
| Hb | hemoglobin |
| Ht | hematocrit |
| IL-6 | interleukin-6 |
| LDH | lactate dehydrogenase |
| MEVs-CK | monocyte-derived extracellular vesicles |
| MF | myelofibrosis (unspecified whether primary or secondary) |
| miR | microRNA |
| MKMVs | megakaryocyte MVs |
| MMPs | monocyte-derived MPs |
| MMVs | monocyte MVs |
| MP | microparticles |
| MPN | myeloproliferative neoplasms |
| MPNu | MPN unclassifiable |
| MVs | microvesicles |
| PaCS | particulate cytoplasmic structures |
| PCA | procoagulant activity |
| PLTs | platelets |
| PLTMVs | platelet MVs |
| PMF | primary myelofibrosis |
| PMAs | platelet microaggregates |
| PMPs | platelet-derived MPs |
| PMCs | platelet-monocyte conjugates |
| PNCs | platelet-neutrophil conjugates |
| PS | phosphatidylserine |
| PV | polycythemia vera |
| RBCs | red blood cells |
| RMPs | red blood cell MPs |
| RT | reactive thrombocytosis |
| RUX | ruxolitinib |
| SMF | secondary MF |
| SP | secondary polycythemia |
| TFMPs | tissue factor-positive MPs |
| TN | triple-negative |
| VAF | variant allele frequency |
| VEFGR2 | vascular endothelial growth factor receptor 2 |
| VTE | venous thromboembolism |
| vs | versus |
| WB | Western Blot |
| WBCs | white blood cell count (leukocytes) |
| ↑ | increased |
| ↓ | decreased |
| (+) | positive |
| (−) | negative |